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Growth inhibition in rats has been produced by the incorpora-
tion of avariety oftoxic compounds into the diet.2" 22, 23, Further,
it has been possible to demonstrate that stimulation of growth occurs
under these experimental conditions when one of the sulfur-contain-
ing amino acids, cysteine, cystine, or methionine, is superimposed on
the basal diet still containing the growth-inhibitory compound.
Under these conditions the animals resume growth at a rate com-
parable to that observed on the basal diet alone. In addition, other
substances, e.g., glutathione and cystine disulfoxide, which are known
to stimulate growth in rats stunted by one of the so-called "cystine-
deficient" diets, have also been shown to be effective growth stimu-
lators when added to the basal, growth-inhibiting diets. Inasmuch
as these growth-promoting dietary supplements exert their action
when injected subcutaneously, as well as following oral administra-
tion, it has been concluded that their effect is a true metabolic one
and not due to a reaction occurring in the intestine prior to
absorption.
The specific and unique capacity of the sulfur-containing amino
acids, and of substances behaving in nutrition experiments in a man-
ner similar to these amino acids, to stimulate the growth of animals
ingestingagrowth-inhibitory basal diet has led to the suggestion that
the inhibition of the growth of the rat by certain organic compounds
"is a manifestation of the production of a specific deficiency in the
sulfur-containing amino acids, probably by imposing on the organism
an increased requirement for organic sulfur, in the form of cystine
or methionine, for detoxication mechanisms."' However, although
direct proof for the formation of a detoxication product (mercap-
turic acid) is clearly established for the monohalogen benzenes, and
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for naphthalene and anthracene, the diverse chemical structures
which have been found to produce similar growth effects and to yield
similar experimental results with various types of supplements sug-
gest some caution in interpreting all of the growth data, obtained in
this type of experimentation, on thebasis of adetoxication mechanism
involving the sulfur-containing amino acids. Until actual isolation of
the detoxication product has been achieved in the case of each growth-
inhibitory chemical compound, the proposed detoxication mechanism
in these instances merely remains a working hypothesis. Indeed, as
has been already suggested,24 it may be that the growth-inhibition is
not, in all cases, related to a specific detoxication mechanism involv-
ing the sulfur-containing amino acids, but that some of these foreign
organic compounds may retard cellular metabolism. In this event,
growth-stimulating sulfur compounds, i.e., l-cystine, l-cysteine,
dl-methionine, l-cystine disulfoxide, and glutathione, may then be
regarded as general cell metabolic stimulants with a consequent effect
on the somatic growth of the organism. The present experiments
were designed to test this possibility. It would appear that an
experimental approach could be made to this problem by the stunting
of young rats with some dietary chemical substance or compound
which, by virtue of its nature or structure, could not theoretically be
detoxicated by a mechanism involving the sulfur-containing amino
acids. Under these experimental conditions, the effects of cystine
or methionine supplements on the growth rate should be of con-
siderable interest.
The growth-inhibitory compound chosen for the present study
is sodium benzoate. The well-established detoxication of benzoate
by conjugation with glycine and with glycuronic acid, and the chemi-
cal structure of benzoic acid, make it unlikely that this compound
would have a growth-inhibitory effect only because of a relationship
to a specific detoxication mechanism involving the sulfur-containing
amino acids. Indeed, the results of this investigation have clearly
demonstrated that growth-inhibition produced in rats by oral admin-
istration ofsodium benzoate is alleviated onlybyglycine and by com-
pounds which appeartobe closelyrelated to glycine from a metabolic
standpoint, i.e., sarcosine and glycolic acid, and is uninfluenced by
dietary supplements of either cystine or methionine. These data
are interpreted as further evidence that growth stimulation produced
by a dietary supplement, despite the simultaneous presence in the
diet of a growth-inhibiting substance, is indicative of the involvement
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of a detoxication mechanism and the formation of some product of
the conjugation of thegrowth-stimulating compound, or its metabolic
products, with the substance causing the growth retardation. Under
these circumstances, growth is resumed because in the presence of
adequate quantities of a growth-promoting dietary supplement, the
latter fulfills the organism's requirements for this particular sub-
stance for both detoxication mechanisms and the synthesis of new
tissue. If an amino acid participating in the detoxication reaction
is derived solely from the tissue proteins, then obviously the stimu-
lating dietary adjunct functions chiefly as replacement for the losses
from the tissue proteins.
During the course of this investigation several other substances
have been tested fortheirgrowth-stimulating effect in rats stunted by
means of asodium benzoate-containing diet. The compounds studied
as supplements were chosen either because they had been demon-
strated to exert an influence on benzoic acid detoxication or because
they have been suggested as playing a rOle in some aspect of glycine
metabolism. After this study was completed, the interest in some of
the dietary supplements was greatly diminished, inasmuch as the
original claims made for the rOle of certain compounds in benzoic
acid detoxication5 were later withdrawn.0
Experimenrtal
The basal diet used was the low-casein ration employed in pre-
vious studies from this laboratory.24 Male rats, at weaning, were
placed in individual cages and given this diet ad libitum. In addi-
tion, each animal received a daily supplement of 400 mg. of dried
yeast.* When the animals reached a body weight of approximately
75 to 85 gm., 5 gm. of sodium benzoate (U.S.P. Powder, Merck)
were added to each I100 gm. of basal diet. Several lower concentra-
tions of benzoate were tried in early preliminary experiments, but it
was foundthat 5 gm. foreach 100 gm. ofbasal diet was the minimum
quantity which could produce marked growth inhibition. After
periods varying from 3 to 6 weeks in length on the stunting diet,
each supplement was incorporated separately into the benzoate-con-
tainingbasal ration in orderto study itseffect on the inhibited growth
rate. Following a period of at least 2 weeks, during which time the
effect of the supplement was determined, animals which had been
* Product of the Northwestern Yeast Co.
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given growth-stimulating supplements were returned to the ben-
zoate-containing basal diet and rats which had received substances
ineffective in relieving the growth inhibition were placed upon a
benzoate-containing basal diet supplemented with glycine. In this
manner each animal served as its own control. The supplements
employed were as follows: glycine (Eastman Kodak Co.), l-cys-
tine (prepared from hair), sarcosine (Hoffmann-La Roche Co.)
dl-methionine (Organic Manufacturers, Universityof Illinois), crea-
tine (Valentine Meat Juice Co.), glycolicacid (Eastman KodakCo.),
TABLE 1
SUMMARY OF AVERAGE WEIGHT CHANGE AND AVERAGE FOOD CONSUMPTION OF
ANIMALS RECEIVING BASAL DIET AND VARIOUS TYPES OF SUPPLEMENTS
Dirt*
Basal
Basal + sodium benzoate
Benzoate-containing basal diet + each
of the following growth-promoting
dietary supplements:
glycine (1.0 gm.)
sarcosine (1.0 gm.)
glycolic acid (1.0 gm.)
glycolic acid (1.5 gm.)
glycolic acid (2.0 gm.)
Benzoate-containing basal diet + each
of the following ineffective dietary
supplements:
I-cystine
dl-methionine
glycocyamine
creatine. H20
l-hydroxyproline
dI-serine
dl-threonine
dl-threonine
sodium sulfate
sodium citrate
(1.0 gm.)
(1.0 gm.)
(1.0 gm.)
(1.25 gm.)
(1.25 gm.)
(1.25 gm.)
(1.0 gm.)
(2.0 gm.)
(1.5 gm.)
(1.5 gm.)
No. of
animas
in
group
115
106
52
7
4
3
7
6
3
2
3
2
3
2
3
2
3
Average daiy
weight change
gm.
+ 1.3
0.0
+ 1.0
+0.7
+ 0.4
+0.8
+ 0.9
-0.1
-0.3
- 0.1
- 1.6
-0.2
-0.3
-0.3
-0.2
-0.8
0.0
Average daily
food
consumption
gm.
6.2
3.3
5.0
5.6
5.1
4.9
5.3
4.6
3.7
4.7
2.1
4.9
3.7
4.2
4.5
4.3
5.1
* The figures in parentheses indicate the levels at which each dietary supplement
was added to each 100 gm. of the benzoate-containing basal diet.BENZOATE FEEDING AND GROWTH
dl-threonine (Organic Manufacturers, University of Illinois), glyco-
cyamine (Hoffmann-La Roche Co.), dl-serine (synthetic), and
l-hydroxyproline (Hoffmann-La Roche Co.). In addition, the
effect of sodium sulfate and of sodium citrate supplements was also
studied. The purity of the nitrogen-containing supplements was
indicated by total nitrogen analyses (micro-Kjeldahl). The purity
ofthe glycolic acid was established by carbon and hydrogen analyses.
The inorganic supplements were commercial preparations of analyti-
cal reagent quality. The data which have been obtained are sum-
marized in Table 1.
Results
The use of sodium benzoate to inhibit the growth of rats was
suggested byGriffith"1 ininvestigations ofthe origin ofglycine. The
latter investigation incorporated sodium benzoate in varying quanti-
ties (1.5 to 3.75 per cent) into a basal diet in which the protein was
furnished by casein at a 35 per cent level. These diets were fed to
young male rats during an experimental period (usually 40 days)
in which careful record of growth rate was made. Survival and
growth of young rats on diets containing benzoate occurred only
when these diets furnished a supply of glycine which was adequate
for the detoxication of the benzoate and for the formation of new
tissue proteins.
The amount of sodium benzoate used in the present experiments
was chosen after a number of preliminary trials. It was desired to
produce rather consistent stunting of the large number of rats
employed in order that the data might be quite uniform. The addi-
tion of 5 gm. of sodium benzoate to each 100 gm. of basal diet pro-
ducedthe desired stuntingwithout any obvious signs of gross toxicity.
Indeed, fourratswere used as long-time controls and were permitted
to ingest thebenzoate-containing basal diet for a period of 23 weeks.
During this time no evidence of toxicity was observed.* Although
the body weights of the animals remained practically stationary dur-
* Although no gross toxicity was apparent in the animals whose data are pre-
sented in Table 1, it should be pointed out that a rat was occasionally seen which
did not tolerate sodium benzoate ingestion and could not be used. In these animals
there was evident a restlessness and irritability, and in a few instances constant
tremors involving the whole body were seen. These symptoms are similar to
those described by Griffith'1 in rats ingesting sodium benzoate. In no case was
diarrhea evident.
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ing this period, the rats were still responsive to the superimposition
of a growth-promoting supplement, e.g., glycine, on the benzoate-
containing basal diet. This responsiveness was manifested as a
prompt resumption of growth and a steadily increased growth rate
as long as the glycine feeding was continued.
The effectiveness of glycine in stimulating the growth of rats
stunted by sodium benzoate is seen from the data in Table 1. The
conjugation of glycine with benzoic acid to form hippuric acid has
been extensively studied by a number of investigators. The
specificity of glycine for this reaction is seen, for example, in the
experiments of Griffith and Lewis.14 The latter investigators
observed that glycine when administered (in 3 molecular equiva-
lents) with benzoic acid to rabbits almost doubled the rate of excre-
tion of hippuric acd as measured by the urinary output in the first 6
hours after feeding. None of the other amino acids studied affected
the rate of excretion in this way. Further, similar data have been
reported in recent publications by Abbott and Lewis.1' 2 The present
growth data are also in complete accord with those of Griffith."1
It will be seen from Table 1 that sarcosine, incorporated into the
benzoate-containing basal diet at the same level as glycine, produced
a growth-stimulating effect comparable to that observed with the
latter amino acid. The effects of sarcosine supplements on benzoate-
containing basal diets were first examined by Gordon and Jackson,*
whose unpublished preliminary data strongly suggested the capacity
of this N-methylated amino acid to function in lieu of glycine in
stimulating the growth of animals stunted by means of benzoate
feeding. Further confirmation of these findings was sought in the
present studyin view of the ability of the N-monomethyl derivatives
of a number of the essential amino acids to replace the unsubstituted
amino acids for purposes of growth in the diet of the young white
rat.8 9, 10, 16, 17, 20 While the present investigation was in progress,
two laboratories independently confirmed the biological conversion
of sarcosine to glycine. Abbott and Lewis' reported that sarcosine,
when fed with benzoicacid, increased the rate ofexcretion of hippuric
acid by the rabbit. Inasmuch as the increased rate of excretion of
conjugated benzoic acid was not due to the formation of N-methyl-
* Private communication. Grateful acknowledgment is made to Dr. Gordon
for discussion of some aspects of the unpublished work conducted in collaboration
with Dr. Jackson. The experiments of the latter investigators are referred to in:
Gordon, W. G., and Jackson, R. W.: J. Biol. Chem., 1939, 110, 151, cf. p. 163.
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hippuric acid, the evidence was interpreted as indicative of the con-
version of sarcosine to glycine. Further proof of this conversion was
obtained inthe experiments of Bloch and Schoenheimer,3 who admin-
istered sarcosine labeled with heavy nitrogen (N15) to adult white
rats and foundthatglycine containing isotopic nitrogen was deposited
in the tissue proteins. Moreover, Borsook and Dubnoff7 have
reported that sarcosine could furnish glycine for the synthesis of
glycocyamine by rat kidney slices. The recent publication of Hand-
ler, Bernheim, and Klein"s is of interest in connection with the
conversion ofsarcosine to glycine. These investigators have demon-
strated the presence in liver tissue of several species (rat, rabbit,
and guinea-pig) of an enzyme capable of oxidatively demethylating
sarcosine to glycine.
The influence of dietary glycolic acid on the growth of rats
stunted by benzoate feeding was examined carefully because of the
demonstration byGriffith'2 that the addition ofsodium glycolate to a
toxic benzoate diet afforded rats practically the same protection as
that furnished by glycine itself. Milhorat and Toscani'9 have
reported a metabolic effect of administered glycolic acid resembling
that of glycine on the creatinuria of patients with progressive muscu-
lar dystrophy. In the present study, the addition of 1 gm. of gly-
colic acid to each 100 gm. of the benzoate-containing basal diet
produced a definite, though not striking, stimulation of growth. As
the level of glycolic acid in the diet was increased (1.5 gm. per 100
gm. ofbenzoate-containing diet), the growth stimulation was marked
and when the amount of the glycolic acid supplement was twice the
level (2 gm.) at which glycine (1 gm.) was tested, the growth-
stimulatory effect approximated closely that seen with glycine. It
may be added that a further increase in the quantity of the glycolic
acid supplement (2.5 gm. per 100 gm. of benzoate-containing diet)
did not further enhance the growth rate but, indeed, resulted in a
manifestation of toxic symptoms with growth of the animals ceasing
entirely. Whilethese experiments werein progress, Professor How-
ard B. Lewis of the University of Michigan stated in a private
communication that experiments in his laboratory had demonstrated
the effectiveness of glycolic acid in augmenting the rate of hippuric
acid excretion in rabbits given sodium benzoate. The full details
of these studies are now available.2 It is of considerable interest
that on the basis of equivalent weights glycolic acid was found to be
less effective than was glycine or sarcosine in increasing the rate of
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hippuric acidexcretion after benzoate feeding. The data were inter-
preted as evidence of the ability of the rabbit to convert glycolic acid
to glycine to a limited extent. The present growth data are in good
agreement with the findings of Abbott and Lewis.
In contrast to the above growth-promoting supplements, each of
the other compounds tested proved completely incapable of stimu-
lating the growth of animals stunted by benzoate feeding. The
sulfur-containing amino aads, l-cystine and dl-methionine, so effect-
ive in alleviating other types of growth inhibition, had no influence
on the growth retardation produced by the benzoate-containing basal
diet. The demands of the organism for glycine, or compounds
which function like this amino acid in metabolism, would seem to be
a manifestation of a specific need for glycine for the detoxication
of benzoic acid. This observation lends further weight to the sug-
gestion that the capacity of the sulfur-containing amino acids (and
of substances behaving in nutrition experiments in a manner similar
to the sulfur-containing amino acids) to stimulate the growth of
animals ingesting a diet containing a foreign, growth-inhibiting sub-
stance is evidence ofthe functioning of these amino acids in processes
concerned with the detoxication of the growth-inhibiting compounds
and not a result of a generalized stimulation of cellular metabolism.
The demonstrated formation of glycocyamine from glycine' 7
led to the testing of the former compound in the present study in
order to determinewhetherthereversetransformation, i.e., glycocya-
mine to glycine, might occur. The inability of glycocyamine to pro-
mote growth under the experimental conditions employed would
appear to argue against the conversion of glycocyamine to glydne
in the organism. Creatine supplements were also ineffective in pro-
moting growth of animals ingesting the benzoate-containing basal
diet. The ineffectiveness of creatine is in conformity with the nega-
tive results with glycocyamine and is also in support of the recent
study of Bloch, Schoenheimer, and Rittenberg4 which demonstrates
the biological resistance of the creatine molecule. The latter,
although beingcontinually synthesized, is not significantly degraded.
Hydroxyproline and serine were studied in the present investiga-
tion because of the preliminary report5 that the synthesis of a sub-
stance which behaves like hippuric acid occurred when either ofthese
two amino acids was added to the liver and kidney tissues of several
species. The inability of these amino acids to stimulate growth in
the benzoate-stunted animals is more in agreement with facts dis-
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closed in a later publication,6 to the effect that although either
hydroxyproline or serine added to rat liver slices does give rise to a
substance which behaves like hippuric acid in the analytical procedure
employed, definite proof remains to be obtained that the compound
being formed in the presence of either hydroxyproline or serine is
actually hippuric acid. The growth data indicate that no conversion
of either of these amino acids to glycine occurs under the present
experimental conditions.
The possibility of a conversion of threonine to glycine was
examined because of the suggestion that ~-hydroxy amino acids are
oxidized at the beta carbon atom; under these circumstances glycine
might arise from threonine in metabolism. However, threonine
added at two different levels to the basal benzoate-containing diet
had no growth-promoting effect. Sodium sulfate and sodium citrate
supplements were tested because of the reports that both sodium
sulfate13 and sodium citrate18 protect animals from the toxic effects
ofdietary benzoate. No evidence of decreased toxicity, as measured
by change ingrowth rate, was seen when either of these sodium salts
was added to the benzoate-containing basal diet.
Summary
1. Inhibition of growth of the young white rat has been pro-
duced by the addition of sodium benzoate to a low-protein basal
diet. The ability of various supplements to affect the growth rate
ofthe animals was studied by the addition of each supplement to the
benzoate-containingbasal diet.
2. Under these experimental conditions, glycine or sarcosine
supplements produced a prompt stimulation of the growth rate.
Glycolic acid, superimposed on the benzoate-containing basal diet in
optimal quantities, resulted in a prompt increase in growth rate; the
growth-promoting effect of glycolic acid under these experimental
conditions is somewhat less marked than is that of either glycine or
sarcosine.
3. A number of other supplements were studied either because
they had been suggested as playingar8le in benzoic acid detoxication
or because they mightthrowlight onthequestion ofwhether growth-
inhibition by a foreign toxic dietary constituent was a manifestation
of an inadequate supply in the organism of a substance required for
the detoxication of the growth-inhibiting substance or whether the
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diminished growth rate was evidence of a generalized inhibited
cellular metabolism. All of the supplements in this group were
without effect on the growth rate of benzoate-stunted animals.
4. It is conduded that the data obtained are further evidence
for the suggestion that the inhibition of the growth of the rat by
certain dietary foreign compounds is a manifestation of the produc-
tion of a deficiency in the normal metabolic substance or substances
specifically concerned with combination with the growth-inhibitory
substance to form a detoxication product.
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